Blog

Important drug development questions that model-based meta-analysis answers

Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…

Matt Zierhut, PhD MBA2026 年 7 月 23 日

Conference

EANM 2026

–

Danielle Pillsbury2026 年 7 月 20 日

Webinar

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Hunter Stephens, PhD2026 年 7 月 17 日

Publication

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Explore how population pharmacokinetic and exposure–response modeling informed brexpiprazole dosing in Japanese patients with agitation…

Certara2026 年 7 月 16 日

On-Demand Webinar

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

Certara2026 年 7 月 13 日

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

Zoe Barter2026 年 7 月 13 日

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Matt Zierhut, PhD MBA2026 年 7 月 9 日

Blog

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…

Hunter Stephens, PhD2026 年 7 月 7 日

Publication

Population PK Modeling Supporting the Aripiprazole Two-Injection Start Regimen in Japanese Patients

Learn how population PK modeling and simulation supported a regulatory strategy for a simplified aripiprazole…

Danielle Pillsbury2026 年 7 月 7 日

Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Alekhya Lavu, PhD, PharmD2026 年 6 月 26 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Certara 服务

Important drug development questions that model-based meta-analysis answers

EANM 2026

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia

Global Health Policy on the Move: Impact of MFN and EU HTA reform on Global and Regional Access

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Dosimetry for radiopharmaceutical therapy: From measurement to dose justification

Population PK Modeling Supporting the Aripiprazole Two-Injection Start Regimen in Japanese Patients

Enhancing clinical trials with real-world evidence in pregnancy research

订阅时事通讯

快捷链接

解决方案

联系我们